Reuters logo
BRIEF-Xiamen Kingdomway Group and unit receive patent license from USPTO
August 24, 2017 / 7:43 AM / 3 months ago

BRIEF-Xiamen Kingdomway Group and unit receive patent license from USPTO

Aug 24 (Reuters) - Xiamen Kingdomway Group Co

* Says it and Inner Mongolia-based pharmaceutical unit received a patent license (US 9,689,008 B2) from United States Patent and Trademark Office, regarding a fermentation method for producing coenzyme Q10

* Patent valid for 20 years and 750 days since the date of application

Source text in Chinese:goo.gl/PhRLpx

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below